Track topics on Twitter Track topics that are important to you
Researchers to Present Data on Immunovaccine's Infectious Disease Pipeline at Three International Conferences / Presentations at RSV16, World Vaccine Congress Europe and IDWeek Conferences Highlight Company's Progress in Using DepoVax-based Agents to
HALIFAX, NOVA SCOTIA -- (Marketwired) -- 09/23/16 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical-stage vaccine and immunotherapy company, today annou...
Company to provide chromatographic expertise to 5-year project, which aims to create a more cost-effective vaccine purification programme
NewsTakeda Pharmaceutical Company Limited announced that it has dosed the first subject in a Phase 2b field efficacy trial of Takeda’s norovirus vaccine candidate, the only norovirus vaccine candid...
Osaka, Japan, June 20, 2016 – Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has dosed the first subject in a Phase 2b field efficacy trial of ...
TORONTO, May 5, 2016 /PRNewswire/ -- Replikins Ltd. today reported initial promising results in animal trials of its Zika vaccine candidates. Logo - http://photos.prnewswire.com/prnh/20160...
As the 69th World Health Assembly discusses progress on the Global Vaccine Action Plan, a new data visualization platform from the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloom...
The HPV vaccine has reduced rates of HPV, but what about the herd effect of the vaccine? Medscape Pediatrics
The short history of the HPV vaccine has been eventful. Will the first vaccine to prevent cancer survive this rocky patch? Medscape Family Medicine
Factors, such as age, comorbidities, vaccine type, herd immunity, previous influenza exposure, and antigenic shift, may impact the immune response to the influenza vaccine, protection against circulat...
As of 2014, routine vaccination strategies in Japan have included the varicella vaccine. Given the widespread use of the vaccine, it is important to investigate the safety profile of the vaccine strai...
Models of implementation of known-effective interventions for HIV prevention indicate that an efficacious vaccine to prevent HIV infection would be critical for controlling the HIV pandemic. Key issue...
Denvaxia is the first licensed vaccine for the prevention of dengue. It is a live vaccine developed using recombinant DNA technology. The vaccine is given as three doses over the course of a year and ...
Background Men who have sex with men (MSM), particularly HIV-infected MSM are disproportionately affected by HPV infection and associated disease. The HPV vaccine has potential to greatly reduce the b...